0001209191-17-028749.txt : 20170428
0001209191-17-028749.hdr.sgml : 20170428
20170428164457
ACCESSION NUMBER: 0001209191-17-028749
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170428
FILED AS OF DATE: 20170428
DATE AS OF CHANGE: 20170428
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LEIDEN JEFFREY M
CENTRAL INDEX KEY: 0001242825
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 17796410
MAIL ADDRESS:
STREET 1: 40 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-04-28
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001242825
LEIDEN JEFFREY M
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
1
0
0
CEO & President
Common Stock
2017-04-28
4
M
0
88507
29.98
A
395152
D
Common Stock
2017-04-28
4
M
0
1527
34.39
A
396679
D
Common Stock
2017-04-28
4
M
0
20000
34.24
A
416679
D
Common Stock
2017-04-28
4
M
0
30000
34.05
A
446679
D
Common Stock
2017-04-28
4
S
0
157200
119.50
D
289479
D
Common Stock
440
I
401k
Stock Option (Right to Buy)
29.98
2017-04-28
4
M
0
88507
0.00
D
2021-12-13
Common Stock
88507
124601
D
Stock Option (Right to Buy)
34.39
2017-04-28
4
M
0
1527
0.00
D
2020-12-14
Common Stock
1527
0
D
Stock Option (Right to Buy)
34.24
2017-04-28
4
M
0
20000
0.00
D
2020-05-31
Common Stock
20000
0
D
Stock Option (Right to Buy)
34.05
2017-04-28
4
M
0
30000
0.00
D
2019-07-05
Common Stock
30000
0
D
Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $119.50 (range $119.50 to $119.60).
Fully vested.
Omar White, Attorney-In-Fact
2017-04-28